Previous 10 | Next 10 |
MURRAY, Utah, Nov. 17, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that, as anticipated, it received a letter from Nasdaq’s Lis...
No Material Impact on 2023 Financial Results; Reaffirms 2023 Outlook No Impact on Cash or Business Operations MURRAY, Utah, Nov. 13, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patien...
2023-11-04 15:58:08 ET R1 RCM Inc. (RCM) Q3 2023 Earnings Conference Call November 2, 2023 08:00 ET Company Participants Evan Smith - Investor Relations Lee Rivas - Chief Executive Officer Jennifer Williams - Chief Financial Officer Conference Call Particip...
R1 RCM Inc. (RCM) is expected to report $0.02 for Q3 2023
2023-11-02 07:23:49 ET More on R1 RCM R1 RCM: Attractively Priced, Capital Produces $0.90/Share In Earnings, Reiterate Buy R1 RCM Q3 2023 Earnings Preview Truist lifts R1 RCM to 'buy' on strong business pipeline; shares up Seeking Alpha’s Quant Rating ...
MURRAY, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced an expansion of its collaboration with Microsoft to accelerate the ...
MURRAY, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2023. ...
2023-11-01 13:37:49 ET More on R1 RCM R1 RCM: Attractively Priced, Capital Produces $0.90/Share In Earnings, Reiterate Buy Truist lifts R1 RCM to 'buy' on strong business pipeline; shares up R1 RCM a new buy at Citi on revenue cycle management outsourcing See...
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM ). The investigation concerns whether RCM and/or certain of its officers have violated th...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages R1 RCM (RCM) Investors with Substantial Losses to Contact Firm’s Attorneys SAN FRANCISCO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM) investors who suffered substantial losses to submit your l...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...
2024-07-08 09:30:06 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for RCM on July 8, 2024 07:50AM ET. The previous analyst recommendation was Overweight. RCM was trading at $10.95 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...